ALDESLEUKIN, IL-2 (al des LOO kin) is a chemotherapy drug. It is usually used for advanced renal cell cancer or for advanced melanoma. It is sometimes used for other cancers.
IL-2 is manufactured using recombinant DNA technology and is marketed as a
protein therapeutic called aldesleukin (branded as Proleukin) by Prometheus ...
Drug type: Aldesleukin is a "biologic response modifier." Aldesleukin is classified
as a "cytokine." (For more detail, see "How this drug works" section below).
(aldesleukin) for injection, for intravenous infusion. Rx Only. WARNINGS.
Therapy with Proleukin. ®. (aldesleukin) should be restricted to patients with.
Learn about Proleukin (aldesleukin), the first FDA-approved immunotherapy for
the treatment of metastatic melanoma.
Feb 15, 2013 ... Aldesleukin injection must be given in a hospital or medical facility under the
supervision of a doctor who is experienced in giving ...
May 11, 2015 ... This page contains brief information about aldesleukin and a collection of links to
more information about the use of this drug, research results, ...
Jan 13, 2014 ... The biological therapy drug aldesleukin is also called Proleukin, interleukin 2 or
IL-2. It is used to treat kidney cancer that has spread. The main ...
Jul 21, 2015 ... Aldesleukin (Proleukin) cancer drug has many side effects and drug interactions.
Aldesleukin is prescribed to treat metastatic kidney cancer ...
Therapy with Proleukin® (aldesleukin) should be restricted to patients with ...
Proleukin® (aldesleukin), a human recombinant interleukin-2 product, is a highly